Journal Guide

Free online access: Inaugural issue New Publishing Partnership This new journal aims to provide a platform to meet the needs of a demanding and growing field, and to serve and engage dialogue between Chinese mycologists and the international community. Mycology publishes papers on all aspects of mycology including lichens, with preference to systematics, ecology and biodiversity, genomics and proteomics, and molecular phylogeny and evolution. Other appropriate subjects for the journal include bioinformatics, physiology and biochemistry, pathology, morphology development, cell biology, genetics, molecular biology, fungal enzymology, fungal metabolites and new techniques. Invitation to Submit Press Release - New Journal Launch The following types of papers will be considered: a) Original Research Articles b) Technical Reviews or Notes reporting new research c) Invited papers All published research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymous refereeing by independent expert referees. STAR Taylor & Francis/Routledge are committed to the widest possible dissemination of its journals to non-profit institutions in developing countries. Our STAR initiative offers individual researchers in Africa, South Asia and many parts of South East Asia the opportunity to gain one month's free online access to 1,300 Taylor & Francis journals. For more information, please visit the STAR website. Disclaimer The Mycological Society of China and Taylor & Francis make every effort to ensure the accuracy of all the information (the 'Content') contained in its publications. However, the Society and Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not necessarily the views of the Editor, the Society or Taylor & Francis.

The journal Mycoses provides an international forum for original papers in English on the pathogenesis, diagnosis, therapy, prophylaxis, and epidemiology of fungal infectious diseases in humans and animals as well as on the biology of pathogenic fungi. Prominent mycoses of the skin have always been the domain of dermatology. Otorhinolaryngologists, gastroenterologists, and gynecologists are confronted with mycoses of the mucous membranes. Medical mycology as part of medical microbiology is advancing rapidly. Effective therapeutic strategies are already available in chemotherapy and are being further developed. Their application requires reliable laboratory diagnostic techniques, which, in turn, result from mycological basic research. Opportunistic mycoses vary greatly in their clinical and pathological symptoms, because the underlying disease of a patient at risk decisively determines their symptomatology and progress. Therefore, case histories are highly informative. Short communications on mycological topics complete the original articles. The journal mycoses is, therefore, of interest to scientists in fundamental mycological research, mycological laboratory diagnosticians, clinicians in all fields, and veterinarians.

The advent of new technologies and growing recognition of the enormous degree of microbial diversity has revolutionized our understanding of microbiology as a discipline. Microbiology is moving into a new era that focuses less on specific organisms and more on the processes and mechanisms that link them. Nature Reviews Microbiology embraces this new era by encompassing the discipline in its broadest sense. We take an integrated approach to microbiology, bridging fundamental research and its clinical, industrial and environmental applications to create a single information resource for all who share an interest in microbial life. Nature Reviews Microbiology publishes the highest-quality reviews and perspectives highlighting important developments in our understanding of bacteria, archaea, viruses, fungi and protozoa, their interaction with their environments, how these organisms are harnessed in human endeavour and their impact on society. Also featured are timely summaries of significant research papers, as well as monthly updates on the latest developments in microbial genomics, post-genomic biology and infectious diseases. In line with our ongoing ambition to overcome the traditional barriers between bacteriology, virology, mycology and archaeal and protozoan biology, articles are tailored to appeal to microbiologists of every persuasion and at every level. The scope of the journal encompasses, but will not be limited to, the following fields pertaining to bacteria, archaea, viruses, fungi and protozoa: * Biochemistry, physiology and molecular biology * Genetics and genomics * Ecology, evolution and biodiversity * Cellular microbiology * Environmental microbiology * Pathogenesis and host defence * Clinical and diagnostic microbiology * Infectious diseases * Antimicrobial therapies and vaccines * Epidemiology and public health microbiology * Applied and industrial microbiology * Microbiology education * Microbiology and society.

New Microbes and New Infections is an official publication of the https://www.escmid.org/European Society of Clinical Microbiology and Infectious Diseases (ESCMID). It serves the field as a peer-reviewed, open access journal for rapid dissemination of the latest research, with a particular focus on new genomes, new microbes, and new technology applied to the diagnosis of infectious/tropical diseases. Article categories include first descriptions of a microbe in a country, first descriptions of resistance in a country, first case reports in a country and mini-reviews, as well as full length original articles. New Microbes and New Infections offers clinicians and researchers a rapid route to publication and the opportunity to publish in a highly visible global forum. The journal draws on the same expert panel of reviewers as http://www.journals.elsevier.com/clinical-microbiology-and-infection/Clinical Microbiology and Infection (CMI). This new journal’s emphasis on concise reports on specific topics distinguishes it from Clinical Microbiology and Infection, which will continue to publish manuscripts presenting basic and applied research in the fields of microbiology, infectious diseases, virology, parasitology, immunology and epidemiology. The open access format of New Microbes and New Infections ensures that accepted manuscripts will be rapidly published and fully accessible by interested professionals worldwide.